|
|
|
|
 |
 |
Clinical studiesColoPlus IMCARE (ONCARE and VET see below)
Nigeria The effect of consuming of ColoPlus on severe diarrhoea associated with HIV-infection was examined in a study at Braithwaite Memorial Specialist Hospital, Port Harcourt, Nigeria on 30 adult patients. Results: Scandinavian Journal of Gastroenterology
Our results were presented at the 5th International Conference on AIDS, India Chennai.
Uganda A follow up, controlled, clinical study by GWED&G / Gulu University Medical School, Uganda and ColoPlus AB was made.
Mrs Pamela Angwech Judith with research team
Ambassador Anders Johnson, left and Counsellor Per Lundell, right, at Swedish Embassy, Kampala, are following our work in Uganda.
ColoPlus AB negotiates Partner Program/Study re Children for ColoPlus IMCARE in India.
ColoPlus ONCARE
Sahlgrenska University Hospital, Gothenburg, Sweden ColoPlus AB signed an agreement regarding clinical study "CAMPIO" - Colostrum Affords Mucosal Protection In Oncology - in collaboration with distinguished Swedish oncologist group.
Ass. professor Tor Ekman, Sahlgrenska University Hospital. Member of the Board, Swedish Cancer Foundation.
CAMPIO - GI. A phase II study to evaluate the efficacy, safety and feasibility of bovine colostrum, administered as ColoPlus ONCARE, as prophylaxis against gastrointestinal side effects during chemotherapy for colorectal cancer.
CAMPIO - F. A phase II study to evaluate the efficacy, safety and feasibility of bovine colostrum, administered as ColoPlus ONCARE, as prophylaxis against fatigue and gastrointestinal side effects during pelvic radiotherapy.
"CAMPIO" clinical studies were approved by Ethical Committee at Sahlgrenska University Hospital.
ColoPlus VET was qualified and planned for a randomized, controlled clinical study at Helsingborg Referral Animal Hospital, Sweden.
|
HIV is a major problem in many countries
|
Press meeting 
